Cargando…
Analysis of Molecular Mechanism of Erxian Decoction in Treating Osteoporosis Based on Formula Optimization Model
Osteoporosis (OP) is a highly prevalent orthopedic condition in postmenopausal women and the elderly. Currently, OP treatments mainly include bisphosphonates, receptor activator of nuclear factor kappa-B ligand (RANKL) antibody therapy, selective estrogen receptor modulators, teriparatide (PTH1-34),...
Autores principales: | Yang, Lang, Fan, Liuyi, Wang, Kexin, Chen, Yupeng, Liang, Lan, Qin, Xuemei, Lu, Aiping, Cao, Peng, Yu, Bin, Guan, Daogang, Peng, Junxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238601/ https://www.ncbi.nlm.nih.gov/pubmed/34239693 http://dx.doi.org/10.1155/2021/6641838 |
Ejemplares similares
-
Effects of Chinese herbal formula Erxian decoction for treating osteoporosis: a systematic review
por: Li, Jin-Yu, et al.
Publicado: (2017) -
Erxian decoction inhibits apoptosis by activating Akt1 and repairs spinal cord injury in rats
por: Li, Erliang, et al.
Publicado: (2022) -
Erxian decoction, a famous Chinese medicine formula, antagonizes corticosterone-induced injury in PC12 cells, and improves depression-like behaviours in mice
por: Zhang, Lan, et al.
Publicado: (2020) -
A System Pharmacology Model for Decoding the Synergistic Mechanisms of Compound Kushen Injection in Treating Breast Cancer
por: Li, Yi, et al.
Publicado: (2021) -
A network pharmacology approach to explore the mechanisms of Erxian decoction in polycystic ovary syndrome
por: Liu, Lihong, et al.
Publicado: (2018)